A
Archana Jain
Researcher at University of Alabama at Birmingham
Publications - 7
Citations - 1771
Archana Jain is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Internal medicine & Population. The author has an hindex of 5, co-authored 5 publications receiving 1670 citations. Previous affiliations of Archana Jain include Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Jasvinder A. Singh,Daniel E. Furst,Aseem Bharat,Jeffrey R. Curtis,Arthur Kavanaugh,Joel M. Kremer,Larry W. Moreland,James O'Dell,Kevin L. Winthrop,Timothy Beukelman,S. Louis Bridges,W. Winn Chatham,Harold E. Paulus,Maria E. Suarez-Almazor,Claire Bombardier,Maxime Dougados,Dinesh Khanna,Charles M. King,Amye L. Leong,Eric L. Matteson,John T. Schousboe,Eileen Moynihan,Karen S. Kolba,Archana Jain,Elizabeth R. Volkmann,Harsh Agrawal,Sangmee Bae,Amy S. Mudano,Nivedita M. Patkar,Kenneth G. Saag +29 more
TL;DR: The 2012 ACR RA recommendations were developed by two expert panels: a non-voting working group and Core Expert Panel of clinicians and methodologists responsible for the selection of the relevant topic areas to be considered, the systematic literature review, and the evidence synthesis.
Journal ArticleDOI
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.
Jeffrey R. Curtis,Archana Jain,Johan Askling,S. Louis Bridges,Loreto Carmona,William G Dixon,Axel Finckh,Kimme L. Hyrich,Jeff Greenberg,Joel M. Kremer,Joachim Listing,Kaleb Michaud,Ted R. Mikuls,Nancy A. Shadick,Daniel H. Solomon,Michael E. Weinblatt,Frederick Wolfe,Angela Zink,Angela Zink +18 more
TL;DR: A careful comparison of selected U.S. and European rheumatoid arthritis biologics registries can provide a basis for understanding the many similarities and differences inherent in their design, as well as societal context and content, all of which can significantly impact their results and comparisons across registers.
Journal ArticleDOI
Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature.
TL;DR: Evidence suggests no increase in risk of cancer with anti-TNF biologics, but there is an increased risk of non-melanoma skin cancer.
Journal ArticleDOI
Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data.
Pongthorn Narongroeknawin,Nivedita M. Patkar,Bita Shakoory,Archana Jain,Jeffrey R. Curtis,Elizabeth Delzell,Philip H Lander,Robert Lopez-Ben,Michael J. Pitt,Monika M. Safford,David A. Volgas,Kenneth G. Saag +11 more
TL;DR: Claims-based algorithms combining hospital discharges with surgeon's diagnosis codes had high PPV to identify the site of subtrochanteric or diaphyseal femoral fractures vs typical hip fractures, however, claims-based data were not accurate in identifying atypical Femoral fractures.
Journal ArticleDOI
Validity of physician-reported hospitalized infections in a US arthritis registry
TL;DR: More than two-thirds of hospitalized infections reported by rheumatologists were confirmed or had evidence that the physician was treating an infection, indicating the possibility of an infection being misclassified.